Tiansheng Pharmaceutical Group Co Ltd (002872) — Net Asset Quality Index
Tiansheng Pharmaceutical Group Co Ltd (002872) has a Net Asset Quality Index of 74.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.65 Billion minus total liabilities of CN¥679.17 Million yields net assets of CN¥1.97 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Tiansheng Pharmaceutical Group Co Ltd for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tiansheng Pharmaceutical Group Co Ltd Net Asset Quality Index Over Time (2012–2024)
This chart shows how Tiansheng Pharmaceutical Group Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 74.4%, representing net assets of CN¥1.97 Billion against total assets of CN¥2.65 Billion CNY. For live market cap and overall valuation, see 002872 market cap overview.
Annual Net Asset Quality Index for Tiansheng Pharmaceutical Group Co Ltd (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Tiansheng Pharmaceutical Group Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 73.6% | CN¥2.01 Billion | CN¥2.74 Billion | CN¥721.80 Million | ▼ -0.9 pp |
| 2023 | 74.6% | CN¥2.10 Billion | CN¥2.81 Billion | CN¥715.25 Million | ▲ +0.9 pp |
| 2022 | 73.7% | CN¥2.19 Billion | CN¥2.97 Billion | CN¥782.23 Million | ▲ +0.6 pp |
| 2021 | 73.1% | CN¥2.28 Billion | CN¥3.12 Billion | CN¥840.79 Million | ▲ +7.5 pp |
| 2020 | 65.5% | CN¥2.39 Billion | CN¥3.65 Billion | CN¥1.26 Billion | ▼ -1.7 pp |
| 2019 | 67.3% | CN¥2.95 Billion | CN¥4.39 Billion | CN¥1.44 Billion | ▼ -0.8 pp |
| 2018 | 68.1% | CN¥3.18 Billion | CN¥4.67 Billion | CN¥1.49 Billion | ▲ +3.6 pp |
| 2017 | 64.5% | CN¥3.19 Billion | CN¥4.95 Billion | CN¥1.76 Billion | ▲ +9.7 pp |
| 2016 | 54.8% | CN¥1.86 Billion | CN¥3.39 Billion | CN¥1.53 Billion | ▼ -2.0 pp |
| 2015 | 56.8% | CN¥1.63 Billion | CN¥2.87 Billion | CN¥1.24 Billion | ▼ -0.5 pp |
| 2014 | 57.4% | CN¥1.43 Billion | CN¥2.50 Billion | CN¥1.06 Billion | ▲ +7.4 pp |
| 2013 | 49.9% | CN¥1.08 Billion | CN¥2.16 Billion | CN¥1.08 Billion | ▼ -4.6 pp |
| 2012 | 54.6% | CN¥951.66 Million | CN¥1.74 Billion | CN¥792.28 Million | — |